what is the most performance mid cap stock between january 13 2025 and february 6 2025

Akero Therapeutics (AKRO) has had the highest return between January 13, 2025 and February 6, 2025 by a mid-cap US stock, returning 134.6%.

ASSET DATE % RETURN
Akero Therapeutics (AKRO)
1/13/2025 - 2/6/2025
134.56%
Oklo (OKLO)
1/13/2025 - 2/6/2025
113.44%
WM Technology (MAPSW)
1/13/2025 - 2/6/2025
110.45%
Tempus AI, Inc Class A Common Stock (TEM)
1/13/2025 - 2/6/2025
105.34%
H&E Equipment Services (HEES)
1/13/2025 - 2/6/2025
100.89%
Rigetti Computing (RGTI)
1/13/2025 - 2/6/2025
88.68%
Hims Hers Health (HIMS)
1/13/2025 - 2/6/2025
70.37%
VNET Group Inc DRC (VNET)
1/13/2025 - 2/6/2025
62.1%
Kingsoft Cloud Holdings  (KC)
1/13/2025 - 2/6/2025
60.93%
Super (SGHC)
1/13/2025 - 2/6/2025
55.23%
Semrush (SEMR)
1/13/2025 - 2/6/2025
46.63%
Compass (COMP)
1/13/2025 - 2/6/2025
43.32%
IONQ (IONQ)
1/13/2025 - 2/6/2025
43.21%
Dana (DAN)
1/13/2025 - 2/6/2025
40.69%
Flagstar Financial (FLG)
1/13/2025 - 2/6/2025
38.71%
Axsome Therapeutics (AXSM)
1/13/2025 - 2/6/2025
38.6%
Corcept Therapeutics (CORT)
1/13/2025 - 2/6/2025
38.34%
BrightSpring Health Services, Inc Common Stock (BTSG)
1/13/2025 - 2/6/2025
38.22%
WNS (WNS)
1/13/2025 - 2/6/2025
37.89%
Brinker International (EAT)
1/13/2025 - 2/6/2025
37.8%
Verona Pharma PLC ADR (VRNA)
1/13/2025 - 2/6/2025
36.02%
OSI Systems (OSIS)
1/13/2025 - 2/6/2025
34.92%
TAL Education (TAL)
1/13/2025 - 2/6/2025
33.26%
Certara (CERT)
1/13/2025 - 2/6/2025
33.24%
Immunitybio (IBRX)
1/13/2025 - 2/6/2025
31.82%
Mid-cap stocks are treated as having a market cap between $2B and $10B.